In accordance with the contrasting effect of LysoPS on these colitis models, the number of IFN-γ–producing CD4+ T cells in the large intestine was substantially increased in Rag2−/− mice that received naive CD4+ T cells compared with DSS-treated mice (Fig. S2 E). The gene discussed is IFNG; the disease is colitis.